 | • レポートコード：GIR201111344 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ジェネリック医薬品有効成分の世界市場を調査対象にし、ジェネリック医薬品有効成分の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子）、用途別分析（腫瘍学、糖尿病、心血管疾患、CNS及び神経障害、内分泌学、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Pfizer, Inc. (U.S.)、GlaxoSmithKline plc (U.K.)、Boehringer Ingelheim (Germany)、Novartis International AG (Switzerland)、Eli Lilly and Company (U.S.)、Sanofi (France)、AbbVie Inc. (U.S.)、Teva Pharmaceutical Industries Ltd. (Israel)、Bristol-Myers Squibb (U.S.)、Merck & Co., Inc. (U.S.) ・メーカー別販売量、売上、市場シェア ・ジェネリック医薬品有効成分の地域別市場分析 ・ジェネリック医薬品有効成分の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ジェネリック医薬品有効成分のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ジェネリック医薬品有効成分のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ジェネリック医薬品有効成分の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ジェネリック医薬品有効成分の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ジェネリック医薬品有効成分の種類別市場規模2015-2020：モノクローナル抗体、ホルモン、サイトカイン、融合タンパク質、治療用酵素、ワクチン、血液因子 ・ジェネリック医薬品有効成分の用途別市場規模2015-2020：腫瘍学、糖尿病、心血管疾患、CNS及び神経障害、内分泌学、その他 ・ジェネリック医薬品有効成分の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Generic Active Pharmaceutical Ingredients market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Generic Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Generic Active Pharmaceutical Ingredients market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Generic Active Pharmaceutical Ingredients market has been segmented into
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors
By Application, Generic Active Pharmaceutical Ingredients has been segmented into:
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Generic Active Pharmaceutical Ingredients market presented in the report. This section sheds light on the sales growth of different regional and country-level Generic Active Pharmaceutical Ingredients markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Generic Active Pharmaceutical Ingredients market.
The report offers in-depth assessment of the growth and other aspects of the Generic Active Pharmaceutical Ingredients market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Generic Active Pharmaceutical Ingredients Market Share Analysis
Generic Active Pharmaceutical Ingredients competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Generic Active Pharmaceutical Ingredients sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Generic Active Pharmaceutical Ingredients sales, revenue and market share for each player covered in this report.
The major players covered in Generic Active Pharmaceutical Ingredients are:
Pfizer, Inc. (U.S.)
GlaxoSmithKline plc (U.K.)
Boehringer Ingelheim (Germany)
Novartis International AG (Switzerland)
Eli Lilly and Company (U.S.)
Sanofi (France)
AbbVie Inc. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Bristol-Myers Squibb (U.S.)
Merck & Co., Inc. (U.S.)
Among other players domestic and global, Generic Active Pharmaceutical Ingredients market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Generic Active Pharmaceutical Ingredients product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Generic Active Pharmaceutical Ingredients, with price, sales, revenue and global market share of Generic Active Pharmaceutical Ingredients in 2018 and 2019.
Chapter 3, the Generic Active Pharmaceutical Ingredients competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Generic Active Pharmaceutical Ingredients breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Generic Active Pharmaceutical Ingredients market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Generic Active Pharmaceutical Ingredients sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Generic Active Pharmaceutical Ingredients Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Generic Active Pharmaceutical Ingredients Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Monoclonal Antibodies
1.2.3 Hormones
1.2.4 Cytokines
1.2.5 Fusion Proteins
1.2.6 Therapeutic Enzymes
1.2.7 Vaccines
1.2.8 Blood Factors
1.3 Market Analysis by Application
1.3.1 Overview: Global Generic Active Pharmaceutical Ingredients Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Cardiovascular Disease
1.3.5 CNS and Neurological Disorders
1.3.6 Endocrinology
1.3.7 Others
1.4 Overview of Global Generic Active Pharmaceutical Ingredients Market
1.4.1 Global Generic Active Pharmaceutical Ingredients Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer, Inc. (U.S.)
2.1.1 Pfizer, Inc. (U.S.) Details
2.1.2 Pfizer, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer, Inc. (U.S.) SWOT Analysis
2.1.4 Pfizer, Inc. (U.S.) Product and Services
2.1.5 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline plc (U.K.)
2.2.1 GlaxoSmithKline plc (U.K.) Details
2.2.2 GlaxoSmithKline plc (U.K.) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline plc (U.K.) SWOT Analysis
2.2.4 GlaxoSmithKline plc (U.K.) Product and Services
2.2.5 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim (Germany)
2.3.1 Boehringer Ingelheim (Germany) Details
2.3.2 Boehringer Ingelheim (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim (Germany) SWOT Analysis
2.3.4 Boehringer Ingelheim (Germany) Product and Services
2.3.5 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis International AG (Switzerland)
2.4.1 Novartis International AG (Switzerland) Details
2.4.2 Novartis International AG (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis International AG (Switzerland) SWOT Analysis
2.4.4 Novartis International AG (Switzerland) Product and Services
2.4.5 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly and Company (U.S.)
2.5.1 Eli Lilly and Company (U.S.) Details
2.5.2 Eli Lilly and Company (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly and Company (U.S.) SWOT Analysis
2.5.4 Eli Lilly and Company (U.S.) Product and Services
2.5.5 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi (France)
2.6.1 Sanofi (France) Details
2.6.2 Sanofi (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi (France) SWOT Analysis
2.6.4 Sanofi (France) Product and Services
2.6.5 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 AbbVie Inc. (U.S.)
2.7.1 AbbVie Inc. (U.S.) Details
2.7.2 AbbVie Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AbbVie Inc. (U.S.) SWOT Analysis
2.7.4 AbbVie Inc. (U.S.) Product and Services
2.7.5 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceutical Industries Ltd. (Israel)
2.8.1 Teva Pharmaceutical Industries Ltd. (Israel) Details
2.8.2 Teva Pharmaceutical Industries Ltd. (Israel) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceutical Industries Ltd. (Israel) SWOT Analysis
2.8.4 Teva Pharmaceutical Industries Ltd. (Israel) Product and Services
2.8.5 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb (U.S.)
2.9.1 Bristol-Myers Squibb (U.S.) Details
2.9.2 Bristol-Myers Squibb (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb (U.S.) SWOT Analysis
2.9.4 Bristol-Myers Squibb (U.S.) Product and Services
2.9.5 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck & Co., Inc. (U.S.)
2.10.1 Merck & Co., Inc. (U.S.) Details
2.10.2 Merck & Co., Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck & Co., Inc. (U.S.) SWOT Analysis
2.10.4 Merck & Co., Inc. (U.S.) Product and Services
2.10.5 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Generic Active Pharmaceutical Ingredients Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Generic Active Pharmaceutical Ingredients Manufacturer Market Share in 2019
3.3.2 Top 6 Generic Active Pharmaceutical Ingredients Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Generic Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Regions
4.1.1 Global Generic Active Pharmaceutical Ingredients Sales and Market Share by Regions (2015-2020)
4.1.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2015-2020)
4.2 North America Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
4.3 Europe Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
4.5 South America Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Generic Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Country
5.1.1 North America Generic Active Pharmaceutical Ingredients Sales and Market Share by Country (2015-2020)
5.1.2 North America Generic Active Pharmaceutical Ingredients Revenue and Market Share by Country (2015-2020)
5.2 United States Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
5.3 Canada Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
5.4 Mexico Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Generic Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Country
6.1.1 Europe Generic Active Pharmaceutical Ingredients Sales and Market Share by Country (2015-2020)
6.1.2 Europe Generic Active Pharmaceutical Ingredients Revenue and Market Share by Country (2015-2020)
6.2 Germany Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
6.3 UK Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
6.4 France Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
6.5 Russia Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
6.6 Italy Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2015-2020)
7.2 China Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
7.3 Japan Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
7.4 Korea Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
7.5 India Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
7.7 Australia Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Generic Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Country
8.1.1 South America Generic Active Pharmaceutical Ingredients Sales and Market Share by Country (2015-2020)
8.1.2 South America Generic Active Pharmaceutical Ingredients Revenue and Market Share by Country (2015-2020)
8.2 Brazil Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
8.3 Argentina Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Generic Active Pharmaceutical Ingredients Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
9.3 Turkey Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
9.4 Egypt Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
9.5 South Africa Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Generic Active Pharmaceutical Ingredients Sales and Market Share by Type (2015-2020)
10.2 Global Generic Active Pharmaceutical Ingredients Revenue and Market Share by Type (2015-2020)
10.3 Global Generic Active Pharmaceutical Ingredients Price by Type (2015-2020)
11 Global Generic Active Pharmaceutical Ingredients Market Segment by Application
11.1 Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application (2015-2020)
11.2 Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Application (2015-2020)
11.3 Global Generic Active Pharmaceutical Ingredients Price by Application (2015-2020)
12 Market Forecast
12.1 Global Generic Active Pharmaceutical Ingredients Sales, Revenue and Growth Rate (2021-2025)
12.2 Generic Active Pharmaceutical Ingredients Market Forecast by Regions (2021-2025)
12.2.1 North America Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025)
12.2.2 Europe Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025)
12.2.3 Asia-Pacific Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025)
12.2.4 South America Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025)
12.2.5 Middle East & Africa Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025)
12.3 Generic Active Pharmaceutical Ingredients Market Forecast by Type (2021-2025)
12.3.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2025)
12.3.2 Global Generic Active Pharmaceutical Ingredients Market Share Forecast by Type (2021-2025)
12.4 Generic Active Pharmaceutical Ingredients Market Forecast by Application (2021-2025)
12.4.1 Global Generic Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2025)
12.4.2 Global Generic Active Pharmaceutical Ingredients Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Generic Active Pharmaceutical Ingredients Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Generic Active Pharmaceutical Ingredients by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Generic Active Pharmaceutical Ingredients Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer, Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Major Business
Table 9. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer, Inc. (U.S.) SWOT Analysis
Table 11. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 12. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. GlaxoSmithKline plc (U.K.) Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Major Business
Table 15. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 16. GlaxoSmithKline plc (U.K.) SWOT Analysis
Table 17. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Product and Services
Table 18. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boehringer Ingelheim (Germany) Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Major Business
Table 21. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 22. Boehringer Ingelheim (Germany) SWOT Analysis
Table 23. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product and Services
Table 24. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis International AG (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 26. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Major Business
Table 27. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 28. Novartis International AG (Switzerland) SWOT Analysis
Table 29. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product and Services
Table 30. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly and Company (U.S.) Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Major Business
Table 33. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 34. Eli Lilly and Company (U.S.) SWOT Analysis
Table 35. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 36. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Sanofi (France) Basic Information, Manufacturing Base and Competitors
Table 38. Sanofi (France) Generic Active Pharmaceutical Ingredients Major Business
Table 39. Sanofi (France) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 40. Sanofi (France) SWOT Analysis
Table 41. Sanofi (France) Generic Active Pharmaceutical Ingredients Product and Services
Table 42. Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. AbbVie Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Major Business
Table 45. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 46. AbbVie Inc. (U.S.) SWOT Analysis
Table 47. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 48. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table 50. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Major Business
Table 51. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 52. Teva Pharmaceutical Industries Ltd. (Israel) SWOT Analysis
Table 53. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Product and Services
Table 54. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bristol-Myers Squibb (U.S.) Basic Information, Manufacturing Base and Competitors
Table 56. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Major Business
Table 57. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 58. Bristol-Myers Squibb (U.S.) SWOT Analysis
Table 59. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 60. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Merck & Co., Inc. (U.S.) Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Major Business
Table 63. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Total Revenue (USD Million) (2018-2019)
Table 64. Merck & Co., Inc. (U.S.) SWOT Analysis
Table 65. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product and Services
Table 66. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Generic Active Pharmaceutical Ingredients Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Generic Active Pharmaceutical Ingredients Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Generic Active Pharmaceutical Ingredients Sales by Regions (2015-2020) (K MT)
Table 70. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Regions (2015-2020)
Table 71. Global Generic Active Pharmaceutical Ingredients Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Generic Active Pharmaceutical Ingredients Sales by Countries (2015-2020) (K MT)
Table 73. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Countries (2015-2020)
Table 74. North America Generic Active Pharmaceutical Ingredients Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries (2015-2020)
Table 76. Europe Generic Active Pharmaceutical Ingredients Sales by Countries (2015-2020) (K MT)
Table 77. Europe Generic Active Pharmaceutical Ingredients Sales Market Share by Countries (2015-2020)
Table 78. Europe Generic Active Pharmaceutical Ingredients Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Generic Active Pharmaceutical Ingredients Sales by Countries (2015-2020) (K MT)
Table 83. South America Generic Active Pharmaceutical Ingredients Sales Market Share by Countries (2015-2020)
Table 84. South America Generic Active Pharmaceutical Ingredients Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries (2015-2020)
Table 90. Global Generic Active Pharmaceutical Ingredients Sales by Type (2015-2020) (K MT)
Table 91. Global Generic Active Pharmaceutical Ingredients Sales Share by Type (2015-2020)
Table 92. Global Generic Active Pharmaceutical Ingredients Revenue by Type (2015-2020) (USD Million)
Table 93. Global Generic Active Pharmaceutical Ingredients Revenue Share by Type (2015-2020)
Table 94. Global Generic Active Pharmaceutical Ingredients Sales by Application (2015-2020) (K MT)
Table 95. Global Generic Active Pharmaceutical Ingredients Sales Share by Application (2015-2020)
Table 96. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Generic Active Pharmaceutical Ingredients Market Share Forecast by Regions (2021-2025)
Table 98. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Generic Active Pharmaceutical Ingredients Market Share Forecast by Type (2021-2025)
Table 100. Global Generic Active Pharmaceutical Ingredients Sales Forecast by Application (2021-2025)
Table 101. Global Generic Active Pharmaceutical Ingredients Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Generic Active Pharmaceutical Ingredients Picture
Figure 2. Global Sales Market Share of Generic Active Pharmaceutical Ingredients by Type in 2019
Figure 3. Monoclonal Antibodies Picture
Figure 4. Hormones Picture
Figure 5. Cytokines Picture
Figure 6. Fusion Proteins Picture
Figure 7. Therapeutic Enzymes Picture
Figure 8. Vaccines Picture
Figure 9. Blood Factors Picture
Figure 10. Generic Active Pharmaceutical Ingredients Sales Market Share by Application in 2018
Figure 11. Oncology Picture
Figure 12. Diabetes Picture
Figure 13. Cardiovascular Disease Picture
Figure 14. CNS and Neurological Disorders Picture
Figure 15. Endocrinology Picture
Figure 16. Others Picture
Figure 17. Global Generic Active Pharmaceutical Ingredients Market Status and Outlook (2015-2025) (USD Million)
Figure 18. United States Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Canada Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Mexico Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Germany Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 22. France Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 23. UK Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Russia Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Italy Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 26. China Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Japan Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Korea Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 29. India Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Southeast Asia Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Australia Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 32. Brazil Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Egypt Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Saudi Arabia Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 35. South Africa Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Turkey Generic Active Pharmaceutical Ingredients Revenue (Value) and Growth Rate (2015-2025)
Figure 37. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Manufacturer in 2019
Figure 38. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Manufacturer in 2019
Figure 39. Top 3 Generic Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2019
Figure 40. Top 6 Generic Active Pharmaceutical Ingredients Manufacturer (Revenue) Market Share in 2019
Figure 41. Key Manufacturer Market Share Trend
Figure 42. Global Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 43. Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions (2015-2020)
Figure 45. Global Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions in 2018
Figure 46. North America Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
Figure 47. Europe Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
Figure 48. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
Figure 49. South America Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
Figure 50. Middle East & Africa Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020)
Figure 51. North America Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Countries (2015-2020)
Figure 53. North America Generic Active Pharmaceutical Ingredients Sales Market Share by Countries in 2018
Figure 54. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 55. North America Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2018
Figure 56. United States Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Canada Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Mexico Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Europe Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries (2015-2020)
Figure 61. Europe Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2019
Figure 62. Germany Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 63. UK Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 64. France Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Russia Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Italy Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share by Regions 2019
Figure 69. Asia-Pacific Generic Active Pharmaceutical Ingredients Revenue Market Share by Regions 2019
Figure 70. China Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Japan Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 72. Korea Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 73. India Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Southeast Asia Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 75. South America Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. South America Generic Active Pharmaceutical Ingredients Sales Market Share by Countries in 2019
Figure 77. South America Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2019
Figure 78. Brazil Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Argentina Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2015-2020) (USD Million)
Figure 81. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share by Countries in 2019
Figure 82. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries (2015-2020)
Figure 83. Middle East and Africa Generic Active Pharmaceutical Ingredients Revenue Market Share by Countries in 2019
Figure 84. Saudi Arabia Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Egypt Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 86. Turkey Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 87. South Africa Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2015-2020) (K MT)
Figure 88. Global Generic Active Pharmaceutical Ingredients Sales and Growth Rate (2021-2025) (K MT)
Figure 89. Global Generic Active Pharmaceutical Ingredients Revenue and Growth Rate (2021-2025) (USD Million)
Figure 90. North America Sales Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025) (K MT)
Figure 91. Europe Sales Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025) (K MT)
Figure 92. Asia-Pacific Sales Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025) (K MT)
Figure 93. South America Sales Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025) (K MT)
Figure 94. Middle East & Africa Sales Generic Active Pharmaceutical Ingredients Market Forecast (2021-2025) (K MT)
Figure 95. Sales Channel: Direct Channel vs Indirect Channel
医薬品有効成分（API）の世界市場 2020年 Market Overview The Active Pharmaceutical Ingredients (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…- 有効化粧品成分の世界市場 2020年 Market Overview The Active Cosmetic Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- ジェネリック医薬品の世界市場 2020年 Market Overview The Generic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- オンコロジージェネリック注射薬の世界市場 2020年 Market Overview The global Oncology Generic Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Ge…
- 化粧品成分の世界市場 2020年 Market Overview The global Cosmetic Ingredients market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 26330 million by 2025, from USD 23000 million in 2019. The Cosmetic Ingredie…